“Trip-Sitting” in the Black Hole: A Netnographic Study of Dissociation and Indigenous Harm Reduction

References

• ACMD. 2011. Consideration of the novel psychoactive substances (“legal highs”). London, UK: Advisory Council on the Misuse of Drugs.
   Google Scholar
• Bonta, I. L. 2004. Schizophrenia, dissociative anaesthesia and near-death experience: Three events meeting at the NMDA receptor. Medical Hypotheses 62 (1):23–28. doi:10.1016/S0306-9877(03)00307-4.
   PubMed Web of Science ®Google Scholar
• Boyer, E. W., P. T. Lapen, G. Macalino, and P. L. Hibberd. 2007. Dissemination of psychoactive substance information by innovative drug users. CyberPsychology and Behavior 10 (1):1–6. doi:10.1089/cpb.2006.9999.
   PubMedGoogle Scholar
• Brandt, S. D., H. R. Sumnall, F. Measham, and J. Cole. 2010. Second generation mephedrone: The confusing case of NRG-1. BMJ 6 (341):3564. doi:10.1136/bmj.c3564.
   Web of Science ®Google Scholar
• Chenail, R. J. 2011. Qualitative researchers in the blogosphere: Using blogs as diaries and data. The Qualitative Report 16 (1):249–54.
   Google Scholar
• Chiauzzi, E., P. DasMahapatra, K. Lobo, and M. J. Baratt. 2013. Participatory research with an online drug forum: A survey of user characteristics, information sharing, and harm reduction views. Substance Use & Misuse 48 (8):661–70. doi:10.3109/10826084.2013.800117.
   PubMed Web of Science ®Google Scholar
• Corazza, O., A. Assi, and F. Schifano. 2013. From “Special K” to “Special M”: The evolution of the recreational use of ketamine and methoxetamine. CNS Neuroscience & Therapeutics 19 (6):454–60. doi:10.1111/cns.12063.
   PubMed Web of Science ®Google Scholar
• Corazza, O., and F. Schifano. 2010. Ketamine use: A prospective study on the emergence of near-death states among a group of 50 ketamine recreational users. Substance Use & Misuse 45:916–24. doi:10.3109/10826080903565321.
   PubMed Web of Science ®Google Scholar
• Corazza, O., F. Schifano, P. Simonato, S. Fergus, S. Assi, J. Stair, J. Corkery, G. Trincas, and N. Scherbaum. 2012. Phenomenon of new drugs on the Internet: The case of ketamine derivative methoxetamine. Human Psychopharmacology: Clinical and Experimental 27 (2):145–49. doi:10.1002/hup.1242.
   PubMed Web of Science ®Google Scholar
• Corazza, O., G. Valeriani, F. S. Bersani, J. Corkery, G. Martinotti, G. Bersani, and F. Schifano. 2014. “Spice,” “Kryptonite,” “Black Mamba”: An overview of brand names and marketing strategies of novel psychoactive substances on the web. Journal of Psychoactive Drugs 46 (4):287–94. doi:10.1080/02791072.2014.944291.
   PubMed Web of Science ®Google Scholar
• Craig, C. L., and G. H. Loeffler. 2014. The ketamine analog methoxetamine: A new designer drug to threaten military readiness. Military Medicine 179 (10):1149–57. doi:10.7205/MILMED-D-13-00470.
   PubMed Web of Science ®Google Scholar
• Crossley, M. 2007. Narrative analysis. In Analysing qualitative data in psychology, ed. E. L. A. Coyle. Los Angeles, CA: Sage.
   Google Scholar
• Curran, V. H., and L. Monaghan. 2001. In and out of the K-hole: A comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 96 (5):749–60. doi:10.1046/j.1360-0443.2001.96574910.x.
   PubMed Web of Science ®Google Scholar
• Dalgarno, P., and D. Shewan. 2005. Reducing the risks of drug use: The case for set and setting. Addiction Research and Theory 13 (3):259–65. doi:10.1080/16066350500053562.
   Web of Science ®Google Scholar
• Deluca, P., Z. Davey, L. Di Furia, M. Farre, H. Flesland, M. Mannonen, A. Majava, T. Peltoniemi, P. Pasinetti, C. Pezzolesi, N. Scherbaum, H. Siemann, A. Skutle, M. Torrens, P. Van Der Kreeft, E. Iversen, and F. Schifano. 2012. Identifying emerging trends in recreational drug use: Outcomes from the psychonaut web mapping project. Psychopharmacology & Biological Psychiatry 39 (2):221–26. doi:10.1016/j.pnpbp.2012.07.011.
   Web of Science ®Google Scholar
• Domino, E. F. 2010. Taming the ketamine tiger. Anesthesiology 113 (3):678–84. doi:10.1097/ALN.0b013e3181ed09a2.
   PubMed Web of Science ®Google Scholar
• Doweiko, H. E. 2011. Concepts of chemical dependency, 8th ed. Belmont, CA: Brookes/Cole.
   Google Scholar
• Downe-Wamboldt, B. 1992. Content analysis: Method, applications and issues. Health Care for Women International 13 (3):313–21. doi:10.1080/07399339209516006.
   PubMedGoogle Scholar
• EMCDDA. 2002. Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Lisbon, Portugal: EMCDDA.
   Google Scholar
• EMCDDA. 2015. New psychoactive substances in Europe: An update from the EU early warning system. Lisbon, Portugal: EMCDDA.
   Google Scholar
• Enarson, M., H. Hays, and M. A. Woodroffe. 1999. Clinical experience with oral ketamine. Journal of Pain and Symptom Management 17 (5):384–86. doi:10.1016/S0885-3924(99)00011-1.
   PubMed Web of Science ®Google Scholar
• Fadiman, J. 2011. The psychedelic explorer’s guide: Safe, therapeutic, and sacred journeys. Rochester, VT: Park Street Press.
   Google Scholar
• Fleming, N. 2010. Briefing: Should miaow-miaow be banned? New Scientist [online]. http://www.newscientist.com/article/dn18672-briefing-should-miaowmiaow-be-banned.html#.VR6e3fnF-So ( accessed October 18, 2014).
   Google Scholar
• Friedman, S., W. De Jong, D. Rossi, G. Touze, R. Rockwell, D. Des Jarlais, and R. Elovich. 2007. Harm reduction theory: Users’ culture, micro-social indigenous harm reduction,and the self-organization and outside-organizing of users’ groups. International Journal of Drug Policy 18 (2):107–17. doi:10.1016/j.drugpo.2006.11.006.
   PubMed Web of Science ®Google Scholar
• Greenspan, N. R., J. P. Aguinaldo, W. Husbands, J. Murray, P. Ho, N. Sutdhibhasilp, J. Cedano, C. Lau, T. Gray, and R. Maharaj. 2011. “It’s not rocket science, what I do”: Self-directed harm reduction strategies among drug using ethno-racially diverse gay and bisexual men. International Journal of Drug Policy 22 (1):56–2. doi:10.1016/j.drugpo.2010.09.004.
   PubMed Web of Science ®Google Scholar
• Hillebrand, J., D. Olszewski, and R. Sedefov. 2010. Legal highs on the Internet. Substance Use and Misuse 45 (3):330–40. doi:10.3109/10826080903443628.
   PubMed Web of Science ®Google Scholar
• Hofer, K. E., B. Grager, D. M. Müller, C. Rauber-Lüthy, H. Kupferschmidt, K. M. Rentsch, and A. Ceschi. 2012. Ketamine-like effects after recreational use of methoxetamine. Annals of Emergency Medicine 60 (1):97–99. doi:10.1016/j.annemergmed.2011.11.018.
   PubMed Web of Science ®Google Scholar
• Hohmann, N., G. Mikus, and D. Czock. 2014. Effects and risks associated with novel psychoactive substances: Mislabeling and sale as bath salts, spice, and research chemicals. Deutsches Arzteblatt International 111 (9):139–47. doi:10.3238/arztebl.2014.0139.
   PubMed Web of Science ®Google Scholar
• Holt, M., and C. Treloar. 2008. Managing mental health problems in everyday life: Drug treatment clients’ self-care strategies. International Journal of Mental Health and Addiction 6 (3):421–31. doi:10.1007/s11469-007-9114-4.
   Google Scholar
• Hsiung, R. C. 2000. The best of both worlds: An online self-help group hosted by a mental health professional. Cyber Psychology & Behavior 3 (6):935–50. doi:10.1089/109493100452200.
   Google Scholar
• Hunt, N., M. Ashton, S. Lenton, L. Mitcheson, B. Nelles, and G. Stimson. 2003. A review of the evidence-base for harm reduction approaches to drug use. London, UK: Forward Thinking on Drugs.
   Google Scholar
• Jansen, K. L. R. 2001. Ketamine: Dreams and realities. Sarasota, FL: MAPS.
   Google Scholar
• Kelly, B. C., B. E. Wells, M. Pawson, A. Leclair, J. T. A. Parsons, and S. A. Golub. 2013. Novel psychoactive drug use among younger adults involved in U.S. nightlife scenes. Drug and Alcohol Review 32 (6):588–93. doi:10.1111/dar.12058.
   PubMed Web of Science ®Google Scholar
• Kjellgren, A., H. Henningsson, and C. Soussan. 2013. Fascination and social togetherness: Discussions about spice smoking on a Swedish Internet forum. Substance Abuse 27 (7):191–98. doi:10.4137/SART.S13323.
   Google Scholar
• Kjellgren, A., and K. Jonsson. 2013. Methoxetamine (MXE): A phenomenological study of experiences induced by a “legal high” from the Internet. Journal of Psychoactive Drugs 45 (3):276–86. doi:10.1080/02791072.2013.803647.
   PubMed Web of Science ®Google Scholar
• Kozinets, R. V. 2002. The field behind the screen: Using netnography for marketing research in online communities. Journal of Marketing Research 39 (1):61–62. doi:10.1509/jmkr.39.1.61.18935.
   Web of Science ®Google Scholar
• Kozlenkov, A., and J. Gonzalez-Maeso. 2013. Animal models and hallucinogenic drugs. In The neuroscience of hallucinations, ed. R. Jardri, A. Cachia, P. Thomas, and D. Pins. New York, NY: Lille: Springer Science + Business Media.
   Google Scholar
• Leary, T., R. Metzner, and R. Alpert. 1964. The psychedelic experience: A manual based on the Tibetan book of the dead. Sacramento, CA: Citadel Press.
   Google Scholar
• Lincoln, Y. S., and E. G. Guba. 1985. Naturalistic inquiry. Beverly Hills, CA: Sage.
   Google Scholar
• Loeffler, G., D. Hurst, A. Penn, and K. Yung. 2012. Spice, bath salts, and the U.S. military: The emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces. Military Medicine 177 (9):1041–48. doi:10.7205/MILMED-D-12-00180.
   PubMed Web of Science ®Google Scholar
• Móró, L., and J. Rácz. 2013. Online drug user-led harm reduction in hungary: A review of “Daath.” Harm Reduction Journal 10:18. doi:10.1186/1477-7517-10-18.
   PubMed Web of Science ®Google Scholar
• Morris, H., and J. Wallach. 2014. From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis 6 (7–8):614–32. doi:10.1002/dta.1620.
   PubMed Web of Science ®Google Scholar
• Muetzelfeldt, L., S. K. Kamboj, H. Rees, J. Taylor, C. J. A. Morgan, and H. V. Curran. 2008. Journey through the k-hole: Phenomenological aspects of ketamine use. Drug and Alcohol Dependence 95 (3):219–29. doi:10.1016/j.drugalcdep.2008.01.024.
   PubMed Web of Science ®Google Scholar
• Panagopoulos, I., and L. A. Ricciardelli. 2005. Harm reduction and decision making among recreational ecstasy users. International Journal of Drug Policy 16 (1):54–64. doi:10.1016/j.drugpo.2004.09.001.
   Web of Science ®Google Scholar
• Roach, M. 2008. Six feet over: Adventures in the afterlife. Edinburgh, UK: Canonogate Books.
   Google Scholar
• Rosenbaum, C. D., S. P. Carrero, and K. M. Babu. 2012. Here today, gone tomorrow… and back again? A review of herbal marijuana alternatives (K2, spice), synthetic cathinones (bath salts), kratom, salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology 8 (1):15–32. doi:10.1007/s13181-011-0202-2.
   PubMedGoogle Scholar
• Roth, B. L., S. Gibbons, W. Arunotayanun, X. Huang, V. Setola, R. Treble, and L. Iversen. 2013. The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS ONE 8 (3):e59334. doi:10.1371/journal.pone.0059334.
   PubMed Web of Science ®Google Scholar
• Saha, S., J. D. Wilson, and H. Adger. 2012. Contemporary Pediatrics 29 (10):22–28.
   Google Scholar
• Saunders, N. 1998. Sitters or guides. http://csp.org/nicholas/A59.html ( accessed January 15, 2015).
   Google Scholar
• Schifano, F., A. Albanese, S. Fergus, J. L. Stair, P. Deluca, O. Corazza, Z. Davey, J. Corkery, H. Siemann, N. Scherbaum, M. Farre, M. Torrens, Z. Demetrovics, and A. H. Ghodse. 2011. Psychonaut web mapping & ReDNet research groups: Mephedrone (4-methylmethcathinone; “meow meow”): Chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 214 (3):593–602. doi:10.1007/s00213-010-2070-x.
   PubMed Web of Science ®Google Scholar
• Schifano, F., J. Corkery, A. Oyefeso, T. Tonia, and A. H. Ghodse. 2008. Trapped in the “K-hole”: Overview of deaths associated with ketamine misuse in the U.K. (1993–2006). Journal of Clinical Psychopharmacology 28 (1):114–16. doi:10.1097/JCP.0b013e3181612cdc.
   PubMed Web of Science ®Google Scholar
• Schmidt, M. M., A. Sharma, F. Schifano, and C. Feinmann. 2010. “Legal highs” on the net: Evaluation of U.K.-based websites, products and product information. Forensic Science International 206 (1–3):92–97. doi:10.1016/j.forsciint.2010.06.030.
   PubMed Web of Science ®Google Scholar
• Secretary’s Advisory Committee on Human Research Protections (SACHRP). 2013. Considerations and recommendations concerning internet research and human subjects research regulations. Washington, DC: Department of Health and Human Services.
   Google Scholar
• Shewan, D., P. Dalgarno, and G. Reith. 2000. Perceived risk and risk reduction among ecstasy users: The role of drug, set, and setting. International Journal of Drug Policy 10 (6):432–53. doi:10.1016/S0955-3959(99)00038-9.
   Google Scholar
• Simonato, P., O. Corazza, P. Santonastaso, J. Corkery, P. Deluca, Z. Davey, U. Blaszko, and F. Schifano. 2013. Novel psychoactive substances as a novel challenge for health professionals: Results from an Italian survey. Human Psychopharmacology 28 (4):324–31. doi:10.1002/hup.2300.
   PubMed Web of Science ®Google Scholar
• Smith, A., and B. Stewart. 2012. Body conceptions and virtual ethnopharmacology in an online bodybuilding community. Performance Enhancement & Health 1 (1):35–38. doi:10.1016/j.peh.2012.04.001.
   Google Scholar
• Solowij, N., W. Hall, and N. Lee. 1992. Recreational MDMA use in Sydney: A profile of “Ecstasy” users and their experiences with the drug. British Journal of Addiction 87 (8):1161–72. doi:10.1111/j.1360-0443.1992.tb02003.x.
   PubMedGoogle Scholar
• Soussan, C., and A. Kjellgren. 2014. Harm reduction and knowledge exchange: A qualitative analysis of drug-related Internet discussion forums. Harm Reduction Journal 11:25. doi:10.1186/1477-7517-11-25.
   PubMed Web of Science ®Google Scholar
• Soussan, C., and A. Kjellgren. 2015. “Chasing the high”: Experiences of ethylphenidate as described on international Internet forums. Substance Abuse: Research and Treatment 9:9–16. doi:10.4137/SART.S22495.
   PubMed Web of Science ®Google Scholar
• Spiller, H. A., M. L. Ryan, R. G. Weston, and J. Jansen. 2011. Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clinical Toxicology 49 (6):499–05. doi:10.3109/15563650.2011.590812.
   PubMed Web of Science ®Google Scholar
• Turner, D. M. 1994. The essential psychedelic guide. San Francisco, CA: Panther Press.
   Google Scholar
• Tylš, F., T. Páleníčeka, and J. Horáčeka. 2013. Psilocybin: Summary of knowledge and new perspectives. European Neuropsychopharmacology 24:342–56. doi:10.1016/j.euroneuro.2013.12.006.
   PubMed Web of Science ®Google Scholar
• UNODC. 2014. Global synthetic drugs assessment: Amphetamine-type stimulants and new psychoactive substances. Vienna, Austria: UNODC.
   Google Scholar
• Van Hout, M. C. 2014a. Nod and wave: An Internet study of the codeine intoxication phenomenon. International Journal of Drug Policy 26 (1):66–77. doi:10.1016/j.drugpo.2014.06.016.
   Web of Science ®Google Scholar
• Van Hout, M. C. 2014b. An Internet study of user’s experiences of the synthetic cathinone 4-methylethcathinone (4-MEC). Journal of Psychoactive Drugs 46 (4):273–86. doi:10.1080/02791072.2014.934979.
   PubMed Web of Science ®Google Scholar
• Van Hout, M. C., and T. Bingham. 2013a. Responsible vendors, intelligent consumers: Silk Road: The online revolution in drug trading. International Journal of Drug Policy 25 (2):183–89. doi:10.1016/j.drugpo.2013.10.009.
   PubMed Web of Science ®Google Scholar
• Van Hout, M. C., and T. Bingham. 2013b. “Surfing the Silk Road”: A study of users’ experiences. International Journal of Drug Policy 24 (6):524–29. doi:10.1016/j.drugpo.2013.08.011.
   PubMed Web of Science ®Google Scholar
• Van Hout, M. C., and E. Hearne. 2015a. “Word of mouse”: Indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine. Journal of Psychoactive Drugs 47 (1):30–41. doi:10.1080/02791072.2014.974002.
   PubMed Web of Science ®Google Scholar
• Van Hout, M. C., and E. Hearne. 2015b. “Plant or poison”: A netnographic study of recreational use of 1,3-Dimethylamylamine (DMAA). International Journal of Drug Policy 26 (12):1279–81. doi:10.1016/j.drugpo.2015.04.002.
   PubMed Web of Science ®Google Scholar
• Van Hout, M. C., and E. Hearne. 2015c. “Vintage meds”: A netographic study of user decision-making, home preparation and consumptive patterns of laudanum. Substance Use & Misuse 50 (5):598–608. doi:10.3109/10826084.2014.991408.
   PubMed Web of Science ®Google Scholar
• Wallendorf, M., and R. W. Belk. 1989. Assessing trustworthiness in naturalistic consumer research. In Interpretive consumer research, ed. E. C. Hirschman. Provo, UT: Association for Consumer Research.
   Google Scholar
• Walsh, C. 2011. Drugs, the Internet and change. Journal of Psychoactive Drugs 43 (1):55–63. doi:10.1080/02791072.2011.566501.
   PubMed Web of Science ®Google Scholar
• Wax, P. M. 2002. Just a click away: Recreational drug web sites on the Internet. Pediatrics 109 (6):e96. doi:10.1542/peds.109.6.e96.
   PubMed Web of Science ®Google Scholar
• Weech, A. A., Jnr., and R. E. Bibb. 1970. Toward a rational approach to psychedelics: The controversy over popular use from a clinical viewpoint. Comprehensive Psychiatry 11 (1):57–68. doi:10.1016/0010-440X(70)90205-1.
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., L. R. Mitcheson, P. Deluca, Z. Davey, O. Corazza, and F. Schifano. 2011. Mephedrone, new kid for the chop? Addiction 106 (1):154–61. doi:10.1111/j.1360-0443.2010.03130.x.
   PubMed Web of Science ®Google Scholar
• Wood, D., and S. Dargan. 2012. Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity. Progress in Neuro–Psychopharmacology & Biological Psychiatry 39 (2):227–33. doi:10.1016/j.pnpbp.2012.04.020.
   PubMed Web of Science ®Google Scholar
• Zinberg, N. 1986. Drug, set, and setting: The basis for controlled intoxicant use. New Haven, CT: Yale University Press.
   Google Scholar